September 14, 2009
Tulane University has announced a cooperative agreement with Repair Technologies, Inc. to develop and manufacture adult stem cells from bone marrow.
Adult stem cells derived from bone marrow avoid the ethical debate that surrounds embryonic stem cells and may be the future of regenerative medicine. Tulane University is recognized as a leader in the production of adult stem cells for research use. In 2003 Tulane received a grant from the National Institutes of Health to establish the first laboratory for the preparation and distribution of bone marrow stem cells to academic scientists at other research centers in the U.S. and abroad.
The work will be done at Tulane University's Good Manufacturing Practices laboratory located in the Tidewater Building at 1440 Canal Street, New Orleans, LA. The facility, developed in partnership with the Louisiana Gene Therapy Research Consortium (LGTRC), was designed to meet the requirements for manufacturing cell therapeutics used in humans. It has been built and operated with funds primarily provided by the state through the Louisiana Board of Regents.
"This is a very exciting collaboration: the first time Tulane’s Good Manufacturing Practices Laboratory is working with a biotech company to develop exciting new clinical therapies," said Brian Butcher, research professor of medicine and associate director of Tulane's Center for Gene Therapy.
"This agreement demonstrates industry's confidence in the LGTRC/Tulane facility, and validates the state's continued support for academic research leading to commercial opportunities," said Steve Moye, president and CEO of Louisiana Gene Therapy Research Consortium.
"Repair is excited to be working with Tulane to bring the promise of stem cell therapy to the clinic," said Dr. Annemarie Moseley, president and CEO of Repair Technologies, Inc.
Tulane University, New Orleans, LA 70118 504-865-5000 email@example.com